ValiRx PLC

LSE:VAL (UK)  
£ 0.10 (0%) Nov 30
At Loss
P/B:
2.68
Market Cap:
£ 10.49M ($ 13.33M)
Enterprise V:
£ 9.63M ($ 12.23M)
Volume:
1.12M
Avg Vol (2M):
1.41M
Also Trade In:
Volume:
1.12M
At Loss
Avg Vol (2M):
1.41M

Business Description

Description
ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, NAV3 for the cancer screening test, and VAL401 for lung cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 30.72
Equity-to-Asset 1.03
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 36.27
9-Day RSI 40.54
14-Day RSI 45.65
12-1 Month Momentum % -47.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.35
Quick Ratio 13.35
Cash Ratio 8.65

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -103.6
Shareholder Yield % -34.79

Profitability Rank

Name Current Vs Industry Vs History
ROE % -64.97
ROA % -65.41
ROIC % -86.55
ROC (Joel Greenblatt) % -837.3
ROCE % -76.18

Financials (Next Earnings Date:2024-06-05 Est.)

LSE:VAL's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

ValiRx PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £)
EPS (TTM) (£) -0.025
Beta -0.47
Volatility % 124.14
14-Day RSI 45.65
14-Day ATR (£) 0.011287
20-Day SMA (£) 0.1159
12-1 Month Momentum % -47.14
52-Week Range (£) 0.051 - 0.17333
Shares Outstanding (Mil) 102.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ValiRx PLC Filings

Filing Date Document Date Form
No Filing Data

ValiRx PLC Stock Events

Event Date Price(£)
No Event Data

ValiRx PLC Frequently Asked Questions

What is ValiRx PLC(LSE:VAL)'s stock price today?
The current price of LSE:VAL is £0.10. The 52 week high of LSE:VAL is £0.17 and 52 week low is £0.05.
When is next earnings date of ValiRx PLC(LSE:VAL)?
The next earnings date of ValiRx PLC(LSE:VAL) is 2024-06-05 Est..
Does ValiRx PLC(LSE:VAL) pay dividends? If so, how much?
ValiRx PLC(LSE:VAL) does not pay dividend.

Press Release

Subject Date
No Press Release